73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Eurofins Scientific SE
Closed
58.76 -1.21
Overview
Share price change
24h
Min
58.26
Max
59.76
Income | -62M 123M |
|---|---|
Sales | -1.7B 1.8B |
P/E Sector Avg | 25.551 22.135 |
EPS | 1.16 |
Dividend yield | 1.03 |
Profit margin | 6.827 |
Employees | 65,000 |
EBITDA | -276M 409M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +11.99% upside |
Dividend yield Sector Avg | 1.03% 4.29% |
|---|
Market Cap | -839M 11B |
|---|---|
Previous open | 59.97 |
Previous close | 58.76 |
Technical Score
By Trading Central
Confidence
Weak Bearish Evidence
Eurofins Scientific SE Chart
Past performance is not a reliable indicator of future results.
Related News
Eurofins Scientific SE Forecast
Price Target
By TipRanks
11.99% upside
12 Months Forecast
Average 66.5 EUR 11.99%
High 72 EUR
Low 61 EUR
Based on 2 Wall Street analysts offering 12 month price targets forEurofins Scientific SE - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Live chat